Therapeutics Taskforce News Today

A report identifying groups in the population at equivalent risk from severe COVID-19 outcomes to any condition in the highest-risk cohort.

Find out how to access coronavirus (COVID-19) treatments outside of hospital, including information on free prescriptions and lateral flow tests.

The DHSC-led COVID-19 Antivirals and Therapeutics Taskforce co-ordinates the end-to-end provision of treatments for coronavirus (COVID-19) in the UK so patients get access to safe and effective treatments as soon as possible.

Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.

New guidance outlines free COVID-19 tests will continue to be available to help protect specific groups once free testing for the general public ends on 1 April

People at risk of serious illness from COVID-19, and eligible for treatments, will continue to get free tests to use if they develop symptoms, along with NHS and adult social care staff and those in other high-risk settings, Health and Social Care Secretary Sajid Javid announced today (Tuesday 29 March).

One dose of Evusheld, which is given as two injections, has been found to reduce the risk of developing symptomatic disease by 77 per cent

Millions more cutting-edge antiviral treatments for COVID-19 have been secured for NHS patients as the UK Government signs two new contracts to help tackle Omicron.

The UK has signed contracts to buy a further 4.25 million courses of antivirals for the NHS

Monumental deals have been accelerated to combat the Omicron variant and protect patients Government urges all over 50s and most vulnerable to sign up